Table 1. Hemodynamic measurements.

		3 d post-MI		8 weeks post-MI
	Normal	Placebo	MSC	Placebo	MSC
LV end-diastolic pressure, mm Hg	8.4 ± 2.3	21.5 ± 5.8*	26 ± 3.6*	29.8 ± 7.6	20 ± 6.4†
LV end-systolic pressure, mm Hg	107.1 ± 4.2	98.8 ± 6.6	112.6 ± 5.6	117.7 ± 22.2	113.8 ± 5.8
Arterial elastance, mm Hg/mm	14 ± 2	20 ± 2.5	24.8 ± 4.2	26.1 ± 8.7	17.1 ± 3
dP/dtmax, mm Hg/s	2,560 ± 266	1,734 ± 218*	1,802 ± 80*	1,720 ± 351	2,465 ± 574†
Ees, mm Hg/mm	16.3 ± 2.4	11.2 ± 0.5*	8.1 ± 3.1*	7.9 ± 1.2	17.1 ± 2†
τ, ms	36.2 ± 1.8	42 ± 1*	44.3 ± 2.3*	52.6 ± 11.6	34.2 ± 1.2†
SW, mm Hg/mm	771 ± 116.5	434.8 ± 59.9*	374.4 ± 59.3*	470.3 ± 86.9	654.4 ± 129.3†
MVO2, J per beat	3.2 ± 0.9	7.4 ± 1.4*	10.3 ± 2*	12.9 ± 1.4‡	3.7 ± 1.8‡
SW/MVO2	9.1 ± 1.6	3.8 ± 0.8*	2.5 ± 0.6*	2.9 ± 0.1‡	10 ± 5.6‡

MVO₂ indicates myocardial oxygen consumption and SW/MVO₂ myocardial efficiency.

^*P < 0.05 vs. normal (pre-MI)

^†P < 0.05 vs. placebo (2-way ANOVA)

^‡Listed values were measured at 4 weeks